PGNX
TD Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-67,500
| Closed | -$257K | – | 1453 |
|
|
2020
Q1 | $257K | Sell |
67,500
-29,500
| -30% | -$112K | ﹤0.01% | 1289 |
|
|
2019
Q4 | $494K | Sell |
97,000
-6,800
| -7% | -$34.6K | ﹤0.01% | 1246 |
|
|
2019
Q3 | $525K | Buy |
103,800
+61,370
| +145% | +$310K | ﹤0.01% | 1162 |
|
|
2019
Q2 | $262K | Buy |
+42,430
| New | +$262K | ﹤0.01% | 1266 |
|